Tandem Diabetes Care to Present Early User Insights on Tandem Mobi at ADA's 84th Scientific Sessions

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent company in insulin delivery and diabetes technology, has announced its lineup of presentations for the American Diabetes Association’s 84th Scientific Sessions. The event is scheduled to take place in Orlando, Florida, from June 21-24.

On June 22, from 10:15 am to 11:00 am EDT, the company will host a Product Theater titled "Meet Tandem Mobi: Tiny pump, big control. The future of Automated Insulin Delivery (AID)." This session will feature new insights from early users of the Tandem Mobi, which is currently the smallest, durable AID system available in the United States since February 2024. The presenters include Jordan Pinsker, MD, Chief Medical Officer at Tandem Diabetes Care; Halis Kaan Akturk, MD, Associate Professor at the Barbara Davis Center for Diabetes, University of Colorado; and Cari Berget, MPH, RN, CDCES, Director of the PANTHER Program and Research Instructor at Barbara Davis Center.

During this presentation, the speakers will elaborate on the unique wearability features of the Tandem Mobi combined with the Control-IQ algorithm, which heralds a new era for AID systems. They will also discuss the advantages of a small-sized insulin delivery system that allows users to disconnect during sports, swimming, and other real-life activities. The session aims to highlight how optimizing algorithm settings can enhance patient outcomes.

Dr. Pinsker stated, “This groundbreaking data is the first presentation of Tandem Mobi user insights and demonstrates our continued commitment to advancing diabetes care through innovative technology.” He emphasized the importance of understanding these early insights to ensure that their portfolio of diabetes solutions provides a positively different experience for customers.

In addition to the Product Theater, Tandem Diabetes Care will also unveil data during the Poster Sessions in the Poster Hall from June 22-24. The company's authors will be present for questions during the General Poster Sessions on June 22 at 12:30 pm EDT. The topics covered in these sessions include:

1. The t:slim X2 with Control-IQ Technology Overcoming Missed Boluses for Moderate Meals, presented by Larry Fu, Alex Trahan, Laurel Messer, and Alex Constantin.
2. What Happens When People Don’t Bolus for Extended Periods while Using the t:slim X2 with Control-IQ Technology? presented by Miranda R. Polin, Andy Johnson, Laurel Messer, Alex Constantin, and Jordan Pinsker.
3. High Time in Closed Loop for Control-IQ Technology with New Interoperable iCGM Sensor, presented by Steph Habif, Sabah Mufti, Michelle Manning, Kevin Wu, and Laurel Messer.
4. High User Satisfaction and Ease of Use Scores with 6 Months Use of the Tandem t:connect Mobile Application, presented by Kimia Assadi, Michelle Manning, Jordan Pinsker, and Laurel Messer.
5. New Paradigms for Wearability with the Tandem Mobi System: Mobi Can Be Worn Many Ways, Early Data Indicate, presented by Steph Habif, Michelle Manning, Scott Leas, Lexi Morgan, and Laurel Messer.

Additionally, Tandem Diabetes Care will exhibit its products at Booth #1621 throughout the ADA event. The Tandem Mobi will be demonstrated alongside the newly launched Dexcom G7 Continuous Glucose Monitoring (CGM) System integration. The t:slim X2, noted as the top-rated automated insulin delivery system, will also be showcased. This system is the first insulin pump compatible with three CGMs: Dexcom G6, Dexcom G7, and Abbott FreeStyle Libre 2 Plus.

Dr. Laurel Messer, Sr. Director of Medical Affairs at Tandem Diabetes Care, will also contribute to the "Bridging Technology and Therapies to Improve Diabetes Outcomes" panel during diaTribe Musings LIVE on June 20 from 5:00 to 7:30 pm EDT at The Gaylord Palms Resort, Emerald Bay Plaza.

About Tandem Diabetes Care: Tandem Diabetes Care, based in San Diego, California, is a global leader in insulin delivery and diabetes technology. The company manufactures and sells advanced automated insulin delivery systems that aim to reduce the burden of diabetes management while offering new possibilities for patients, their families, and healthcare providers. Their product lineup includes the Tandem Mobi system and the t:slim X2 insulin pump, both featuring the Control-IQ advanced hybrid closed-loop technology.